Report Detail

Other Global Atrophic Gastritis Treatment Market Size, Status and Forecast 2018-2025

  • RnM2389513
  • |
  • 04 September, 2018
  • |
  • Global
  • |
  • 91 pages
  • |
  • QYResearch
  • |
  • Other

Global Atrophic Gastritis Treatment Market Size, Status and Forecast 2018-2025

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Atrophic Gastritis Treatment Market Size Growth Rate by Type (2013-2025)
      • 1.4.2 Coating Agents
      • 1.4.3 Antibiotics
      • 1.4.4 Vitamin B-12
    • 1.5 Market by Application
      • 1.5.1 Global Atrophic Gastritis Treatment Market Share by Application (2013-2025)
      • 1.5.2 Hospital Pharmacies
      • 1.5.3 Retail Pharmacies
      • 1.5.4 Drug Stores
      • 1.5.5 Online Pharmacies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Atrophic Gastritis Treatment Market Size
    • 2.2 Atrophic Gastritis Treatment Growth Trends by Regions
      • 2.2.1 Atrophic Gastritis Treatment Market Size by Regions (2013-2025)
      • 2.2.2 Atrophic Gastritis Treatment Market Share by Regions (2013-2018)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Atrophic Gastritis Treatment Market Size by Manufacturers
      • 3.1.1 Global Atrophic Gastritis Treatment Revenue by Manufacturers (2013-2018)
      • 3.1.2 Global Atrophic Gastritis Treatment Revenue Market Share by Manufacturers (2013-2018)
      • 3.1.3 Global Atrophic Gastritis Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Atrophic Gastritis Treatment Key Players Head office and Area Served
    • 3.3 Key Players Atrophic Gastritis Treatment Product/Solution/Service
    • 3.4 Date of Enter into Atrophic Gastritis Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Atrophic Gastritis Treatment Market Size by Type (2013-2018)
    • 4.2 Global Atrophic Gastritis Treatment Market Size by Application (2013-2018)

    5 United States

    • 5.1 United States Atrophic Gastritis Treatment Market Size (2013-2018)
    • 5.2 Atrophic Gastritis Treatment Key Players in United States
    • 5.3 United States Atrophic Gastritis Treatment Market Size by Type
    • 5.4 United States Atrophic Gastritis Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Atrophic Gastritis Treatment Market Size (2013-2018)
    • 6.2 Atrophic Gastritis Treatment Key Players in Europe
    • 6.3 Europe Atrophic Gastritis Treatment Market Size by Type
    • 6.4 Europe Atrophic Gastritis Treatment Market Size by Application

    7 China

    • 7.1 China Atrophic Gastritis Treatment Market Size (2013-2018)
    • 7.2 Atrophic Gastritis Treatment Key Players in China
    • 7.3 China Atrophic Gastritis Treatment Market Size by Type
    • 7.4 China Atrophic Gastritis Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Atrophic Gastritis Treatment Market Size (2013-2018)
    • 8.2 Atrophic Gastritis Treatment Key Players in Japan
    • 8.3 Japan Atrophic Gastritis Treatment Market Size by Type
    • 8.4 Japan Atrophic Gastritis Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Atrophic Gastritis Treatment Market Size (2013-2018)
    • 9.2 Atrophic Gastritis Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Atrophic Gastritis Treatment Market Size by Type
    • 9.4 Southeast Asia Atrophic Gastritis Treatment Market Size by Application

    10 India

    • 10.1 India Atrophic Gastritis Treatment Market Size (2013-2018)
    • 10.2 Atrophic Gastritis Treatment Key Players in India
    • 10.3 India Atrophic Gastritis Treatment Market Size by Type
    • 10.4 India Atrophic Gastritis Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Atrophic Gastritis Treatment Market Size (2013-2018)
    • 11.2 Atrophic Gastritis Treatment Key Players in Central & South America
    • 11.3 Central & South America Atrophic Gastritis Treatment Market Size by Type
    • 11.4 Central & South America Atrophic Gastritis Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Takeda Pharmaceutical Company Limited
      • 12.1.1 Takeda Pharmaceutical Company Limited Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Atrophic Gastritis Treatment Introduction
      • 12.1.4 Takeda Pharmaceutical Company Limited Revenue in Atrophic Gastritis Treatment Business (2013-2018)
      • 12.1.5 Takeda Pharmaceutical Company Limited Recent Development
    • 12.2 PERNIX Therapeutics
      • 12.2.1 PERNIX Therapeutics Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Atrophic Gastritis Treatment Introduction
      • 12.2.4 PERNIX Therapeutics Revenue in Atrophic Gastritis Treatment Business (2013-2018)
      • 12.2.5 PERNIX Therapeutics Recent Development
    • 12.3 Perrigo Pharmaceutical
      • 12.3.1 Perrigo Pharmaceutical Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Atrophic Gastritis Treatment Introduction
      • 12.3.4 Perrigo Pharmaceutical Revenue in Atrophic Gastritis Treatment Business (2013-2018)
      • 12.3.5 Perrigo Pharmaceutical Recent Development
    • 12.4 Teva Pharmaceutical
      • 12.4.1 Teva Pharmaceutical Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Atrophic Gastritis Treatment Introduction
      • 12.4.4 Teva Pharmaceutical Revenue in Atrophic Gastritis Treatment Business (2013-2018)
      • 12.4.5 Teva Pharmaceutical Recent Development

    13 Market Forecast 2018-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2018-2025)
    • 13.10 Market Size Forecast by Application (2018-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      This report focuses on the global Atrophic Gastritis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Atrophic Gastritis Treatment development in United States, Europe and China.

      Atopic gastritis is chronic inflammation of gastric mucosa, and it is a histopathological condition associated with gastric glandular cell and replacement by fibrous tissue, intestinal type epithelium, and pyloric type glands. It mainly associated H. Pylori bacterial infection, and autoimmunity directed against gastric glandular cell. Symptoms include stomach pain, loss of appetite, nausea, unexpected weight loss, iron deficiency anemia. There is a high chance for the development of pernicious anemia in autoimmune atrophic gastritis Individual due to the loss of anti-intrinsic antibodies and parietal cell mass. Atrophic gastritis associated with H. Pylori are at high risk of developing gastric carcinoma and is frequently asymptomatic. Individuals associated with chronic atrophic gastritis develop hypergastrinemia and low gastric acid output which may lead to carcinoid tumors and enterochromaffin-like cell hyperplasia. Atrophic gastritis develops at childhood and if, it is left untreated atrophic gastritis progress throughout the lifespan.  Treatment mainly includes antibiotics for eliminating H. Pylori bacteria. Symptomatic treatment includes vitamin B-12 injections. Proton pump inhibitors used to control the acidity of the stomach.  Autoimmune atrophic gastritis associated with gastric polyps, pernicious anemia, and adenocarcinoma. Atrophic gastritis diagnosed by low levels of B-12, low levels of pepsinogen, high levels of gastrin and intrinsic factors.
      Atrophic gastritis is associated with loss of gastric gland and is a progressive condition with the replacement of metaplasia. It is asymptomatic and associated with large complications like gastric carcinoma, hyperplasia, hypergastrinemia, increased risk of heart attack in elderly. The frequency of atrophic gastritis is unknown due to it is mostly asymptomatic. Atrophic gastritis is extremely common and is highly prevalent in different parts of the globe. In atrophic gastritis, eradication of H. Pylori is highly complicated, and it requires follow-up for several years. Eradication of H. Pylori reduces the risk of developing cancers in late stages. Mortality and morbidity associated with atrophic gastritis are depended on underlying complications of diseases. Atrophic gastritis requires a continuous management because recurrence of illness is high.  All these factors act as a driver in the robust growth of the atrophic gastritis treatment market.
      In 2017, the global Atrophic Gastritis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

      The key players covered in this study
      Takeda Pharmaceutical Company Limited
      PERNIX Therapeutics
      Perrigo Pharmaceutical
      Teva Pharmaceutical
      ...

      Market segment by Type, the product can be split into
      Coating Agents
      Antibiotics
      Vitamin B-12

      Market segment by Application, split into
      Hospital Pharmacies
      Retail Pharmacies
      Drug Stores
      Online Pharmacies

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Atrophic Gastritis Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Atrophic Gastritis Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Atrophic Gastritis Treatment are as follows:
      History Year: 2013-2017
      Base Year: 2017
      Estimated Year: 2018
      Forecast Year 2018 to 2025
      For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Atrophic Gastritis Treatment . Industry analysis & Market Report on Atrophic Gastritis Treatment is a syndicated market report, published as Global Atrophic Gastritis Treatment Market Size, Status and Forecast 2018-2025. It is complete Research Study and Industry Analysis of Atrophic Gastritis Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $7,800.00
      3,202.68
      6,405.36
      3,516.87
      7,033.74
      415,334.40
      830,668.80
      279,789.51
      559,579.02
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report